Variant report
Variant | esv1009040 |
---|---|
Chromosome Location | chr3:84950754-84962040 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:31)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:31 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BHLHE40 | chr3:84954233-84954576 | HepG2 | liver: | n/a | n/a |
2 | CEBPB | chr3:84958863-84959065 | A549 | lung: | n/a | chr3:84958954-84958965 |
3 | CEBPB | chr3:84958813-84959139 | HepG2 | liver: | n/a | chr3:84958954-84958965 |
4 | CTCF | chr3:84957003-84957054 | GM13977 | blood: | n/a | n/a |
5 | MAFK | chr3:84951991-84952306 | HepG2 | liver: | n/a | chr3:84952232-84952247 |
6 | MAFK | chr3:84952074-84952262 | HepG2 | liver: | n/a | chr3:84952232-84952247 |
7 | MYC | chr3:84954337-84954511 | MCF-7 | breast: | n/a | n/a |
8 | POLR2A | chr3:84954260-84954262 | Gliobla | brain: | n/a | n/a |
9 | POLR2A | chr3:84954118-84954141 | A549 | lung: | n/a | n/a |
10 | POLR2A | chr3:84955223-84955401 | MCF-7 | breast: | n/a | n/a |
11 | POLR2A | chr3:84954156-84954217 | A549 | lung: | n/a | n/a |
12 | POLR2A | chr3:84954049-84954648 | MCF-7 | breast: | n/a | n/a |
13 | POLR2A | chr3:84954177-84954297 | MCF-7 | breast: | n/a | n/a |
14 | POLR2A | chr3:84955292-84955472 | A549 | lung: | n/a | n/a |
15 | POLR2A | chr3:84955280-84955466 | MCF-7 | breast: | n/a | n/a |
16 | POLR2A | chr3:84959190-84959229 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | POLR2A | chr3:84950848-84950900 | GM12878 | blood: | n/a | n/a |
18 | POLR2A | chr3:84955415-84955416 | MCF-7 | breast: | n/a | n/a |
19 | POLR2A | chr3:84956448-84956489 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | POLR2A | chr3:84954107-84954160 | MCF-7 | breast: | n/a | n/a |
21 | POLR2A | chr3:84954378-84954393 | MCF-7 | breast: | n/a | n/a |
22 | POLR2A | chr3:84955215-84955218 | MCF-7 | breast: | n/a | n/a |
23 | POLR2A | chr3:84954264-84954422 | A549 | lung: | n/a | n/a |
24 | POLR2A | chr3:84954075-84954096 | MCF-7 | breast: | n/a | n/a |
25 | SIN3A | chr3:84954186-84954285 | H1-hESC | embryonic stem cell: | n/a | n/a |
26 | STAT3 | chr3:84956284-84956334 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | STAT3 | chr3:84956077-84956180 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | USF1 | chr3:84953448-84953670 | SK-N-SH_RA | brain: | n/a | n/a |
29 | USF1 | chr3:84953442-84953668 | H1-hESC | embryonic stem cell: | n/a | n/a |
30 | USF1 | chr3:84953464-84953654 | H1-hESC | embryonic stem cell: | n/a | n/a |
31 | ZNF143 | chr3:84954222-84954251 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000266025 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs113087543 | chr3:84950885-84950886 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs182236895 | chr3:84952005-84952006 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs145085853 | chr3:84952106-84952107 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs539984142 | chr3:84952125-84952126 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs139991363 | chr3:84952143-84952144 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs547363649 | chr3:84952196-84952197 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs565922181 | chr3:84952244-84952245 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs539364073 | chr3:84952285-84952286 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs188323705 | chr3:84952290-84952291 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs57155100 | chr3:84952298-84952299 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs115776078 | chr3:84953446-84953447 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs575961143 | chr3:84953563-84953564 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs1691487 | chr3:84953580-84953581 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs560407438 | chr3:84953583-84953584 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs555175259 | chr3:84953587-84953588 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs36107387 | chr3:84953641-84953642 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs1694958 | chr3:84953642-84953643 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs559223477 | chr3:84953643-84953644 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs114557692 | chr3:84953655-84953656 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs1694957 | chr3:84953865-84953866 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs184868936 | chr3:84953866-84953867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs548886567 | chr3:84953922-84953923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs1691485 | chr3:84953926-84953927 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs548492303 | chr3:84953951-84953952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs547058332 | chr3:84953952-84953953 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs1691484 | chr3:84953992-84953993 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs111593496 | chr3:84953997-84953998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs539124222 | chr3:84954003-84954004 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs73135623 | chr3:84954030-84954031 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs569297073 | chr3:84954061-84954062 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs536926277 | chr3:84954074-84954075 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs34496036 | chr3:84954105-84954106 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs555338896 | chr3:84954167-84954168 | Enhancers Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs72543825 | chr3:84954203-84954204 | Enhancers Genic enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs534175643 | chr3:84954236-84954237 | Enhancers Genic enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs559110278 | chr3:84954257-84954258 | Enhancers Genic enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs1694956 | chr3:84954289-84954290 | Enhancers Genic enhancers Flanking Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs544718759 | chr3:84954313-84954314 | Enhancers Genic enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs562915119 | chr3:84954356-84954357 | Enhancers Genic enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs574921550 | chr3:84954362-84954363 | Enhancers Genic enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs369668867 | chr3:84954379-84954380 | Enhancers Genic enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs115224464 | chr3:84954431-84954432 | Enhancers Genic enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs373504435 | chr3:84954442-84954443 | Enhancers Genic enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs528283857 | chr3:84954451-84954452 | Enhancers Genic enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs375457274 | chr3:84954481-84954482 | Enhancers Genic enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs546430023 | chr3:84954552-84954553 | Enhancers Genic enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs1691482 | chr3:84954574-84954575 | Enhancers Genic enhancers Flanking Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs372655067 | chr3:84954602-84954603 | Weak transcription Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs35368396 | chr3:84954630-84954631 | Weak transcription Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs558932932 | chr3:84954689-84954690 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Mental retardation | 17124404 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Schizophrenia | 23813976 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Autism | 22102821 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:84953800-84955600 | Enhancers | Fetal Muscle Leg | muscle |
2 | chr3:84954000-84954200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr3:84954000-84954200 | Enhancers | Psoas Muscle | Psoas |
4 | chr3:84954000-84954200 | Active TSS | Skeletal Muscle Male | skeletal muscle |
5 | chr3:84954000-84954200 | Enhancers | Skeletal Muscle Female | skeletal muscle |
6 | chr3:84954000-84955600 | Enhancers | Fetal Muscle Trunk | muscle |
7 | chr3:84954200-84954600 | Enhancers | H1 Cell Line | embryonic stem cell |
8 | chr3:84954200-84954600 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr3:84954200-84954600 | Enhancers | Muscle Satellite Cultured Cells | -- |
10 | chr3:84954200-84954600 | Flanking Active TSS | Psoas Muscle | Psoas |
11 | chr3:84954200-84954600 | Flanking Active TSS | Skeletal Muscle Male | skeletal muscle |
12 | chr3:84954200-84955400 | Flanking Active TSS | Skeletal Muscle Female | skeletal muscle |
13 | chr3:84954600-84954800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr3:84954600-84955000 | Enhancers | Skeletal Muscle Male | skeletal muscle |
15 | chr3:84954600-84955400 | Enhancers | Psoas Muscle | Psoas |
16 | chr3:84955000-84955400 | Flanking Active TSS | Skeletal Muscle Male | skeletal muscle |
17 | chr3:84955400-84955600 | Enhancers | Skeletal Muscle Male | skeletal muscle |
18 | chr3:84955400-84955600 | Enhancers | Skeletal Muscle Female | skeletal muscle |